US Pharma MarketingThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
The Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.
Source: BioPharma Dive